Market watch: Benefits and costs of immunizing children against influenza at school: An economic analysis based on a large-cluster controlled clinical trial

Health Affairs

Volumn 27, Issue 2, 2008, Pages

  Schmier, Jordana ^a   Li, Su ^b   King Jr , James C ^c   Nichol, Kristin ^d   Mahadevia, Parthiv J ^b  

^a EXPONENT INC   (United States)

^b MEDIMMUNE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; UNSPECIFIED SIDE EFFECT; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; ECONOMICS; HEALTH CARE QUALITY; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SCHOOL HEALTH SERVICE; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COST SAVINGS; COST-BENEFIT ANALYSIS; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, ECONOMIC; PROGRAM EVALUATION; SCHOOL HEALTH SERVICES; UNITED STATES;

EID: 41749097276     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.2.w96     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention, "CDC's Advisory Committee Recommends Expanded Influenza Vaccinations for Children," Press Release, 23 February 2006, http://www.cdc.gov/od/oc/media/pressrel/r060223.htm (accessed 6March 2007).
2. See, for example, P.A. Piedra et al., "Herd Immunity in Adults against Influenza-Related Illnesses with Use of the Trivalent-Live Attenuated Influenza Vaccine (CAIV-T) in Children," Vaccine 23, no. 13 (2005): 1540-1548;
3. S. Cauchemez et al., "A Bayesian MCMC Approach to Study Transmission of Influenza: Application to Household Longitudinal Data," Statistics in Medicine 23, no. 22 (2004): 3469-3487;
4. C. Viboud et al., "Risk Factors of Influenza Transmission in Households," British Journal of General Practice 54, no. 506 (2004): 684-689;
5. and T.A. Reichert et al., "The Japanese Experience with Vaccinating Schoolchildren against Influenza," New England Journal of Medicine 344, no. 12 (2001): 889-896.
6. "Estimated Influenza Vaccination Coverage among Adults and Children - United States, September 1-November 30, 2004," Morbidity and Mortality Weekly Report 53, no. 49 (2004): 1147-1153.
7. J.C. King Jr. et al., "Effectiveness of School-Based Influenza Vaccination," New England Journal of Medicine 355, no. 24 (2006): 2523-2532.
8. L.A. Prosser et al., "Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children," Emerging Infectious Diseases 12, no. 10 (2006): 1548-1558;
9. and M.I. Meltzer et al., "An Economic Analysis of Annual Influenza Vaccination of Children," Vaccine 23, no. 8 (2005): 1004-1014.
10. King, "Effectiveness of School-Based Influenza Vaccination."
11. The full details of this study are available in an online supplement at http://content.healthaffairs.org/cgi/content/full/hlthaff.27.2.w96/DC2.
12. King, "Effectiveness of School-Based Influenza Vaccinationn."
13. Detailed information on the types of costs and sources are provided in an online Appendix, as in Note 7.
14. CDC, "2004-05 U.S. Influenza Season Summary," 7 July 2005, http://www.cdc.gov/flu/weekly/weeklyarchives2004-2005/04-05summary.htm (accessed 26 December 2007).
15. N.M. Smith et al., "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)," Morbidity and Mortality Weekly Report 55 (28 June 2006): 1-41.
16. "Update: Influenza Activity - United States and Worldwide, 2005-06 Season, and Composition of the 2006-07 Influenza Vaccine," Morbidity and Mortality Weekly Report 55, no. 23 (2006): 648-653.
17. A.E. Fiore et al., "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)," Morbidity and Mortality Weekly Report 56, no. RR06 (2007): 1-54.
18. CDC, "2004-05 U.S. Influenza Season Summary." 15. R.B. Belshe et al., "Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children," New England Journal of Medicine 356, no. 7 (2007): 685-696;
19. and R.B. Belshe et al., "Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine against a Variant (A/Sydney) Not Contained in the Vaccine," Journal of Pediatrics 136, no. 2 (2000): 168-175.
20. American Lung Association, "Influenza Fact Sheet," May 2006, http://www.lungusa.org/site/pp.asp?c=dvLUK9O0E&b=35434 (accessed 10 January 2008);
21. California Department of Health Services, "California Influenza Surveillance Project Summary 2004-2005," http://www.dhs.ca.gov/ps/dcdc/ VRDL/html/FLU/Flutable04-05.htm (accessed 6March 2007);
22. Bureau of Laboratories and Bureau of Epidemiology, "Influenza Laboratory Surveillance Data," http://www.michigan.gov/documents/ Infl_Season_Rpt_2004-2005_131419_7.pdf (accessed 11 January 2008);
23. Public Health Agency of Canada, "Influenza in Canada-2004-2005 Season," Canada Communicable Disease Report 32, no. 6 (2006);
24. and T. Vesikari et al., "Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care," Pediatrics 118, no. 6 (2006): 2298-2312.
25. Chalkboard Project, "Issue Paper: Using Average Daily Attendance as a Basis for Distributing State School Revenue," http://www. chalkboardproject.org/images/PDF/Attendance.pdf (accessed 2 January 2008).
26. King, "Effectiveness of School-Based Influenza Vaccination."
27. J.C. King Jr. et al., "A Pilot Study of the Effectiveness of a School-Based Influenza Vaccination Program," Pediatrics 116, no. 6 (2005): e868-e873.
28. M. Krahn et al., "Costs and Cost-Effectiveness of a Universal, School-Based Hepatitis B Vaccination Program," American Journal of Public Health 88, no. 11 (1998): 1638-1644;
29. M.S. Coleman et al., "Estimating Medical Practice Expenses from Administering Adult Influenza Vaccinations," Vaccine 23, no. 7 (2005): 915-923;
30. and C.B. Bridges et al., "Effectiveness and Cost-Benefit of Influenza Vaccination of Healthy Working Adults: A Randomized Controlled Trial," Journal of the American Medical Association 284, no. 13 (2000): 1655-1663.
31. J. King, "School-Based Mass Influenza Immunization Program Using Volunteers" (Unpublished paper, University of Maryland, Baltimore, 2006).